Federico Nasroulah
Executive Director, Global Clinical Lead, Oncology Clinical Development Daiichi Sankyo
Seminars
Wednesday 5th November 2025
Exploring the Clinical Profile & Journey of Datroway from TROPION-Breast Trials & Assessing Future Directions in Solid Tumor Indications
9:00 am
- Detailing clinical data from TROPION-Breast01 trial with US and Japanese approval in previously metastatic HR positive, HER2 negative breast cancer
- Exploring fresh insights from TROPION-Breast02 in triple negative breast cancer
- Looking ahead to TROPION-Breast 03, 04, and 05 trials and highlighting other investigations of Datroway in solid tumorsÂ
